Literature DB >> 30827144

Sudden Cardiac Death in Hypertensive Patients.

Paolo Verdecchia1, Fabio Angeli2, Claudio Cavallini1, Adolfo Aita1, Dario Turturiello2, Michelantonio De Fano3, Gianpaolo Reboldi3.   

Abstract

In patients with hypertension, but without established cardiovascular disease, predictive factors for sudden cardiac death (SCD) remain undefined. We followed for an average of 10.3 years a cohort of 3242 initially untreated hypertensive patients without evidence of coronary or cerebrovascular heart disease at entry. All patients underwent a complete clinical examination which included ECG and 24-hour ambulatory blood pressure monitoring. At entry, the mean age of patients was 50.0 years, 45% were women, and 6.1% had type 2 diabetes mellitus. Average office blood pressure was 154/96 mm Hg, and average 24-hour ambulatory blood pressure was 136/86 mm Hg. Prevalence of left ventricular hypertrophy at ECG was 13.9%. During follow-up, SCD occurred in 33 patients at a rate of 0.10 per 100 patient-years (95% CI, 0.07-0.14). The rate of SCD was 0.07 and 0.30 per 100 patient-years, respectively, in the cohort of patients without and with ECG left ventricular hypertrophy ( P<0.01). In a multivariable Cox model with Firth penalized maximum bias reduction method for rare outcome events, left ventricular hypertrophy almost tripled the risk of SCD (adjusted hazard ratio, 2.99; 95% CI, 1.47-6.09; P=0.002) after adjustment for age ( P<0.0001), sex ( P=0.019), diabetes mellitus ( P<0.0001), and 24-hour ambulatory pulse pressure ( P=0.036). For each 10 mm Hg increase in 24-hour ambulatory pulse pressure, the risk of SCD increased by 35%. The time-dependent area under the receiver operating characteristic curve was 0.85 (95% CI, 0.74-0.96). We conclude that in patients with hypertension without established cardiovascular disease, age, diabetes mellitus, ECG left ventricular hypertrophy, and 24-hour ambulatory pulse pressure are independent prognostic markers for SCD in the long-term.

Entities:  

Keywords:  blood pressure; diabetes mellitus; hypertension; hypertrophy; prognosis

Mesh:

Year:  2019        PMID: 30827144     DOI: 10.1161/HYPERTENSIONAHA.119.12684

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk.

Authors:  Goran Koracevic; Milovan Stojanovic; Dragan Lovic; Marija Zdravkovic; Dejan Sakac
Journal:  J Hum Hypertens       Date:  2021-03-02       Impact factor: 3.012

Review 2.  Antihypertensive therapy and sudden cardiac death, should we expect the unexpected?

Authors:  Elias Sanidas; Konstantinos Malliaras; Dimitrios Papadopoulos; Maria Velliou; Konstantinos Tsakalis; Kanella Zerva; John Barbetseas
Journal:  J Hum Hypertens       Date:  2020-01-14       Impact factor: 3.012

3.  Prevalence and associated factors of electrocardiographic left ventricular hypertrophy in a rural community, central Thailand.

Authors:  Patipan Viwatrangkul; Sakda Lawanwisut; Pondfah Leekhaphan; Tatchamon Prasart-Intara; Pathomphon Phiensuparp; Sirapat Prakiatpongsa; Promnavaporn Amnaj; Vichaya Phoominart; Krittanan Chanyou; Peeratuth Jiratrakan; Pisit Klumnaimueang; Nattapat Pipitdaecha; Rawin Panchamawat; Pannathorn Tangkongpanich; Mathirut Mungthin; Ram Rangsin; Boonsub Sakboonyarat
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

4.  Multimodal imaging shows fibrosis architecture and action potential dispersion are predictors of arrhythmic risk in spontaneous hypertensive rats.

Authors:  Prashanna Khwaounjoo; Gregory B Sands; Ian J LeGrice; Girish Ramulgun; Jesse L Ashton; Johanna M Montgomery; Anne M Gillis; Bruce H Smaill; Mark L Trew
Journal:  J Physiol       Date:  2022-08-31       Impact factor: 6.228

Review 5.  Left ventricular hypertrophy and sudden cardiac death.

Authors:  Grigorios Giamouzis; Apostolos Dimos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2021-06-28       Impact factor: 4.214

6.  Association between body mass index and risk of cardiovascular disease-specific mortality among adults with hypertension in Shanghai, China.

Authors:  Jing Hu; Huilin Xu; Jingjing Zhu; Jinling Zhang; Jun Li; Linli Chen; Xiaohua Liu; Guoyou Qin
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

7.  Reverse electromechanical modelling of diastolic dysfunction in spontaneous hypertensive rat after sacubitril/valsartan therapy.

Authors:  Yen-Ling Sung; Ting-Tse Lin; Jhen-Yang Syu; Hung-Jui Hsu; Kai-Yuan Lin; Yen-Bin Liu; Shien-Fong Lin
Journal:  ESC Heart Fail       Date:  2020-09-24

Review 8.  Is hypertensive left ventricular hypertrophy a cause of sustained ventricular arrhythmias in humans?

Authors:  R Nadarajah; P A Patel; M H Tayebjee
Journal:  J Hum Hypertens       Date:  2021-03-05       Impact factor: 3.012

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.